Laakso M
Department of Medicine, University of Kuopio, Finland.
J Diabetes Complications. 1997 Mar-Apr;11(2):137-41. doi: 10.1016/s1056-8727(96)00092-x.
Lipid and lipoprotein abnormalities in non-insulin-dependent diabetes mellitus (NIDDM) include particularly elevated levels of total and very-low-density lipoprotein (VLDL) triglycerides and reduced levels of high-density lipoprotein (HDL) cholesterol. Total and low-density lipoprotein (LDL) cholesterol levels are usually normal if glycemic control is adequate. The worsening of glycemic control deteriorates lipid and lipoprotein abnormalities and particularly total and LDL cholesterol levels are often elevated in patients with poor glycemic control. According to prospective population-based studies total cholesterol is a powerful risk factor for coronary heart disease (CHD) in NIDDM patients as in nondiabetic subjects. In contrast, high total triglycerides and low HDL cholesterol may be even stronger risk factors for CHD in NIDDM patients than in nondiabetic individuals, but more prospective studies are needed to substantiate this view. Compositional changes in LDL and VLDL particles may further increase the risk for CHD but epidemiologic data are missing to support this notion. Preliminary data from the Scandinavian Simvastatin Survival Study including 202 diabetic patients seem to indicate that diabetic patients benefit from simvastatin treatment equally to nondiabetic subjects.
非胰岛素依赖型糖尿病(NIDDM)中的脂质和脂蛋白异常尤其包括总甘油三酯和极低密度脂蛋白(VLDL)甘油三酯水平升高,以及高密度脂蛋白(HDL)胆固醇水平降低。如果血糖控制良好,总胆固醇和低密度脂蛋白(LDL)胆固醇水平通常正常。血糖控制恶化会使脂质和脂蛋白异常加剧,血糖控制不佳的患者中总胆固醇和LDL胆固醇水平常常升高。根据基于人群的前瞻性研究,与非糖尿病患者一样,总胆固醇是NIDDM患者冠心病(CHD)的一个强大危险因素。相比之下,高总甘油三酯和低HDL胆固醇可能是NIDDM患者比非糖尿病个体更强的CHD危险因素,但需要更多前瞻性研究来证实这一观点。LDL和VLDL颗粒的组成变化可能会进一步增加CHD风险,但缺乏流行病学数据支持这一观点。来自斯堪的纳维亚辛伐他汀生存研究的初步数据(包括202名糖尿病患者)似乎表明,糖尿病患者从辛伐他汀治疗中获得的益处与非糖尿病患者相同。